In fact, elevated ANLN expression was observed in many other human cancers and ANLN expression was proposed to be a prognostic and therapeutic indicator for breast cancer, colorectal cancer, lung cancer and upper urinary tract urothelial carcinoma [8,9,11,12,15]. The gene discussed is ANLN; the disease is breast cancer.